Stockreport

Sanofi outlays $1.9bn to purchase Dren Bio's bispecific antibody [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The deal for the clinical asset will be made through Sanofi's acquisition of Dren Bio affiliate Dren-0201. The French company will pay $600m upfront, with milestone pay [Read more]